»search site
The International Academy of Cardiology is dedicated to Cardiology Online - International Academy of Cardiologythe advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Discussion Groups
   Job Opportunities
   Contact Us





21st World Congress on Heart Disease



Tadeusz Malinski, Ph.D., Ohio University, Athens, OH, USA


Background: A dysfunctional endothelium is a common denominator in aging and several cardiovascular diseases: hypertension, diabetes, salt-induced hypertension and atherosclerosis. Dysfunctional endothelium is characterized by diminished concentrations of cytoprotective nitric oxide (NO) and an overproduction of cytotoxic peroxynitrite (ONOO-) and superoxide (O2-).

Methods & Results: A nanomedical approach was utilized to directly measure with nanosensors (diameter of 150-250 nm) the near real time (1microsecond) changes of NO, O2- and ONOO- concentrations released from endothelial cells. The concentration ratio of [NO] to [ONOO-] and [O2-] was used to quantify the level of endothelial dysfunction. The studies presented here elucidate different treatments of dysfunctional endothelium which may lead to the correction/restoration of endothelial function and to hinder the rate of progression of aging and /or cardiovascular disease. [NO]/[ONOO-] ratio in normal endothelium is about 3-5 and the ratio uf [NO]/[ONOO-+[O2-] is in the range of about 1.8-2.7. In cellular and/or animal models of hypertension, diabetes or aging, the [NO]/[ONOO-]+[O2-] ratio is usually below 0.70 and can decrease dramatically to a level of 0.1 in advanced stages of disease.

There are two major sources that contribute to the generation of O2-in endothelium, uncoupled eNOS and NAD(P)H. NO is an efficient scavenger of O2- to produce ONOO-. Uncoupled eNOS accounts for about 60% of O2-, while about 40% is produced by NAD(P)H. In normal endothelium, the major source of O2- production comes from NAD(P)H, while production from eNOS is negligible. Several different treatments were used to elucidate the restoration/improvement of endothelial function: scavenging of O2- (PEG-SOD), scavenging of ONOO- (Mn(III) TM PyP), increase of eNOS coupling and the efficiency of NO production (NAD(P)H, L-arginine, sepiapterin and statins). Using these various treatments separately or in combination can restore dysfunctional endothelium by 70-95% in cellular and animal models of hypertension, diabetes and aging.



©1998-2017 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.